Богомолова А. А.¹, Федосеева Е. С.², Сидорин А. В.³, Крючков И. Р.³, Фурминская Е. Ю.², Гриневич В. Н.^{2, 4}

¹ГБУЗ г. Москвы «Городская клиническая больница им. С. С. Юдина Департамента здравоохранения г. Москвы»; Россия, 115446 Москва, Коломенский проезд, 4;

²Медицинский радиологический научный центр им. А. Ф. Цыба – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России; Россия, 249036 Обнинск, ул. Королева, 4;

³филиал компании «Хадасса Медикал Лтд»; Россия, 121205 Москва, территория инновационного центра «Сколково», Большой бульвар, 46 / 1;

⁴Московский научно-исследовательский онкологический институт им. П.А. Герцена – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России; Россия, 125284 Москва, 2‑й Боткинский проезд, 3

1. Stein H., Foss H.D., Dürkop H. et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 2000;96(12):3681–95.

2. D’Orsi G., Giacalone M., Calicchia A. et al. BIA-ALCL and BIA-SCC: updates on clinical features and genetic mutations for latest recommendations. Medicina (Kaunas) 2024;60(5):793. DOI: 10.3390/medicina60050793

3. Swerdlow S.H., Campo E., Pileri S.A. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127(20):2375–90. DOI: 10.1182/blood-2016-01-643569

4. Thomas A., Link B.K., Altekruse S. et al. Primary breast lymphoma in the United States: 1975–2013. J Natl Cancer Inst 2017;109(6):djw294. DOI: 10.1093/jnci/djw294

5. Oliveira A.C.P., Maino M., Zanin E.M. et al. Breast implants follow-up: results of a cross-sectional study on patients submitted to MRI breast examinations. Aesthetic Plast Surg 2021;45(1):27–34. DOI: 10.1007/s00266-020-01962-1

6. de Boer M., van Leeuwen F.E., Hauptmann M. et al. Breast implants and the risk of anaplastic large-cell lymphoma in the breast. JAMA Oncol 2018;4(3):335–41. DOI: 10.1001/jamaoncol.2017.4510

7. Collett D.J., Rakhorst H., Lennox P. et al. Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants. Plast Reconstr Surg 2019;143(3S A review of breast implant-associated anaplastic large cell lymphoma):30S–40S. DOI: 10.1097/PRS.0000000000005567

8. De Jong D., Vasmel W.L., de Boer J.P. et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA 2008;300(17):2030–5. DOI: 10.1001/jama.2008.585

9. Мантурова Н.Е., Абдулаев Р.Т., Устюгов А.Ю. Ассоциированная с грудным имплантом анапластическая крупноклеточная лимфома. Пластическая хирургия и эстетическая медицина 2020;(2):5–14. DOI: 10.17116/plast.hirurgia20200215 Manturova N.E., Abdulaev R.T., Ustyugov A.Yu. Breast implantassociated anaplastic large cell lymphoma. Plasticheskaya khirurgiya i esteticheskaya meditsina = Plastic Surgery and Aesthetic Medicine 2020;(2):5–14. (In Russ.). DOI: 10.17116/plast.hirurgia20200215

10. Борисова О.В., Петров А.Н. Цитологическая диагностика анапластической крупноклеточной лимфомы молочной железы, ассоциированной с имплантом. Новости клинической цитологии России 2023;27(1):11–4. (In Russ.). DOI: 10.24412/1562-4943-2023-1-0002 Borisova O.V., Petrov A.N. Cytological diagnosis of breast implantassociated anaplastic large cell lymphoma. Novosti klinicheskoy tsitologii Rossii = Russian News of Clinical Cytology 2023;27(1):11–4. DOI: 10.24412/1562-4943-2023-1-0002

11. Чернова Н.Г., Звонков Е.Е., Ковригина А.М. и др. Ассоциированная с имплантатом анапластическая крупноклеточная лимфома молочной железы: описание клинического случая и обзор литературы. Терапевтический архив 2017;89(7):93–8. DOI: 10.17116/terarkh201789793-98 Chernova N.G., Zvonkov E.E., Kovrigina A.M. et al. Breast implant-associated anaplastic large-cell lymphoma: a case report and a review of literature. Terapevticheskii arkhiv = Therapeutic Archive 2017;89(7):93–8. DOI: 10.17116/terarkh201789793-98

12. Deva A.K., Turner S.D., Kadin M.E. et al. Etiology of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): Current directions in research. Cancers (Basel) 2020;12(12):3861. DOI: 10.3390/cancers12123861

13. Alotaibi S., Hamadani M., Al-Mansour M., Aljurf M. Breast implant-associated anaplastic large cell lymphoma. Clin Lymphoma Myeloma Leuk 2021;21(3):e272–6. DOI: 10.1016/j.clml.2020.12.005

14. Rastogi P., Riordan E., Moon D., Deva A.K. Theories of etiopathogenesis of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg 2019;143(3S A review of breast implant-associated anaplastic large cell lymphoma):23S–9S. DOI: 10.1097/PRS.0000000000005566

15. de Boer M., van der Sluis W.B., de Boer J.P. et al. Breast implantassociated anaplastic large-cell lymphoma in a transgender woman. Aesthet Surg J 2017;37(8):NP83–7. DOI: 10.1093/asj/sjx098

16. Ali N., Sindhu K., Bakst R.L. A rare case of a transgender female with breast implant-associated anaplastic large cell lymphoma treated with radiotherapy and a review of the literature. J Investig Med High Impact Case Rep 2019;7:2324709619842192. DOI: 10.1177/2324709619842192

17. Yu H., Pardoll D., Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009;9(11):798–809. DOI: 10.1038/nrc2734

18. Turner S.D., Inghirami G., Miranda R.N., Kadin M.E. Cell of origin and immunologic events in the pathogenesis of breast implant-associated anaplastic large-cell lymphoma. Am J Pathol 2020;190(1):2–10. DOI: 10.1016/j.ajpath.2019.09.005

19. Oishi N., Brody G.S., Ketterling R.P. et al. Genetic subtyping of breast implant-associated anaplastic large cell lymphoma. Blood 2018;132(5):544–7. DOI: 10.1182/blood-2017-12-821868

20. Blombery P., Thompson E.R., Jones K. et al. Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implantassociated anaplastic large cell lymphoma anaplastic large cell lymphoma. Haematologica 2016;101(9):e387–90. DOI: 10.3324/haematol.2016.146118

21. Wolfram D., Rabensteiner E., Grundtman C. et al. T regulatory cells and TH17 cells in peri-silicone implant capsular fibrosis. Plast Reconstr Surg 2012;129(2):327e–37e. DOI: 10.1097/PRS.0b013e31823aeacf

22. Hieken T.J., Chen J., Hoskin T.L. et al. The microbiome of aseptically collected human breast tissue in benign and malignant disease. Sci Rep 2016;6:30751. DOI: 10.1038/srep30751

23. Bartsich S., Ascherman J.A., Whittier S. et al. The breast: a cleancontaminated surgical site. Aesthet Surg J 2011;31(7):802–6. DOI: 10.1177/1090820X11417428

24. Hu H., Jacombs A., Vickery K. et al. Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma. Plast Reconstr Surg 2015;135(2):319–29. DOI: 10.1097/PRS.0000000000000886

25. Ajdic D., Zoghbi Y., Gerth D. et al. The relationship of bacterial biofilms and capsular contracture in breast implants. Aesthet Surg J 2016;36(3):297–309. DOI: 10.1093/asj/sjv177

26. Jacombs A., Tahir S., Hu H. et al. In vitro and in vivo investigation of the influence of implant surface on the formation of bacterial biofilm in mammary implants. Plast Reconstr Surg 2014;133(4):471e–80e. DOI: 10.1097/PRS.0000000000000020

27. Alessandri-Bonetti M., Jeong T., Vaienti L. et al. The role of microorganisms in the development of breast implant-associated anaplastic large cell lymphoma. Pathogens 2023;12(2):313. DOI: 10.3390/pathogens12020313

28. Loch-Wilkinson A., Beath K.J., Knight R.J.W. et al. Breast Implant-associated anaplastic large cell lymphoma in Australia and New Zealand: High-surface-area textured implants are associated with increased risk. Plast Reconstr Surg 2017;140(4):645–54. DOI: 10.1097/PRS.0000000000003654

29. Pearle A.D., Crow M.K., Rakshit D.S. et al. Distinct inflammatory gene pathways induced by particles. Clin Orthop Relat Res 2007;458:194–201. DOI: 10.1097/BLO.0b013e3180320ae8

30. Fleury E.F., Rêgo M.M., Ramalho L.C. et al. Silicone-induced granuloma of breast implant capsule (SIGBIC): similarities and differences with anaplastic large cell lymphoma (ALCL) and their differential diagnosis. Breast Cancer (Dove Med Press) 2017;9:133–40. DOI: 10.2147/BCTT.S126003

31. Bizjak M., Selmi C., Praprotnik S. et al. Silicone implants and lymphoma: The role of inflammation. J Autoimmun 2015;65:64–73. DOI: 10.1016/j.jaut.2015.08.009

32. Lidgren L. Chronic inflammation, joint replacement and malignant lymphoma. J Bone Joint Surg Br 2008;90(1):7–10. DOI: 10.1302/0301-620X.90B1.19823

33. Kellogg B.C., Hiro M.E., Payne W.G. Implant-associated anaplastic large cell lymphoma: beyond breast prostheses. Ann Plast Surg 2014;73(4):461–4. DOI: 10.1097/SAP.0b013e31827faff2

34. Palraj B., Paturi A., Stone R.G. et al. Soft tissue anaplastic large T- cell lymphoma associated with a metallic orthopedic implant: case report and review of the current literature. J Foot Ankle Surg 2010;49(6):561–4. DOI: 10.1053/j.jfas.2010.08.009

35. De Jong W.H., Panagiotakos D., Proykova A. et al. Final opinion on the safety of breast implants in relation to anaplastic large cell lymphoma: Report of the scientific committee on health, emerging and environmental risks (SCHEER). Regul Toxicol Pharmacol 2021;125:104982. DOI: 10.1016/j.yrtph.2021.104982

36. Evans M.G., Medeiros L.J., Marques-Piubelli M.L. et al. Breast implant-associated anaplastic large cell lymphoma: clinical followup and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease. Mod Pathol 2021;34(12):2148–53. DOI: 10.1038/s41379-021-00842-6

37. Miranda R.N., Aladily T.N., Prince H.M. et al. Breast implantassociated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol 2014;32(2):114–20. DOI: 10.1200/JCO.2013.52.7911

38. Roden A.C., Macon W.R., Keeney G.L. et al. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol 2008;21(4):455–63. DOI: 10.1038/modpathol.3801024

39. Aladily T.N., Medeiros L.J., Amin M.B. et al. Anaplastic large-cell lymphoma associated with breast implants: A report of 13 cases. Am J Surg Pathol 2012;36(7):1000–8. DOI: 10.1097/PAS.0b013e31825749b1

40. Miranda P., Moita F., Vargas Moniz J., Rodrigues Dos Santos C. Breast implant-associated anaplastic large cell lymphoma: Two distinct clinical presentations. Acta Med Port 2022;35(11):835–9. DOI: 10.20344/amp.16578

41. Di Napoli A., Pepe G., Giarnieri E. et al. Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma. PLoS ONE 2017;12(7):e0181097. DOI: 10.1371/journal.pone.0181097

42. Quesada A.E., Medeiros L.J., Clemens M.W. et al. Breast implantassociated anaplastic large cell lymphoma: a review. Mod Pathol 2019;32(2):166–88. DOI: 10.1038/s41379-018-0134-3

43. Longo B., Di Napoli A., Curigliano G. et al. Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL. Breast 2022;66:332–41. DOI: 10.1016/j.breast.2022.11.009

44. Desai K.M., Angadi P.V., Kale A.D., Hallikerimath S. Modified alcohol-formalin cell block technique in head and neck pathology diagnosis. Acta Cytologica 2018;62:39–43. DOI: 10.1159/000484195

45. Mukhtar R.A., Holland M., Sieber D.A. et al. Synchronous breast implant-associated anaplastic large cell lymphoma and invasive carcinoma: Genomic profiling and management implications. Plast Reconstr Surg Glob Open 2019;7(4):e2188. DOI: 10.1097/GOX.0000000000002188

46. Safari A., Hamza S., Paton D. A rare case: synchronous ipsilateral breast implant-associated anaplastic large cell lymphoma and invasive ductal carcinoma. J Surg Case Rep 2023;2023(6):rjad338. DOI: 10.1093/jscr/rjad338

47. Cordeiro P.G., Ghione P., Ni A. et al. Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants. J Plast Reconstr Aesthet Surg 2020;73(5):841–6. DOI: 10.1016/j.bjps.2019.11.064